Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockade

Brain Research

Volumn 1229, Issue , 2008, Pages 27-36

  Akerman, Simon ^a   Holland, Philip R ^a   Goadsby, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aura; Cortical spreading depression; Migraine; Sodium channel

Indexed keywords

CALCIUM CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CAT; CONTROLLED STUDY; FEMALE; HYPEREMIA; LASER DOPPLER FLOWMETRY; MALE; MECHANICAL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CATS; CEREBRAL CORTEX; FEMALE; HYPEREMIA; LASER-DOPPLER FLOWMETRY; MALE; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SODIUM CHANNEL BLOCKERS; SPREADING CORTICAL DEPRESSION; TETRODOTOXIN;

RATTUS;

EID: 49849102137     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.014     Document Type: Article

References (52)

1. Akerman S., and Goadsby P.J. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. NeuroReport 16 (2005) 1383-1387
2. + channel blockade. Cephalalgia 25 (2005) 871
3. Akerman S., Williamson D., and Goadsby P.J. Voltage-dependent calcium channels are involved in neurogenic dural vasodilation via a pre-synaptic transmitter release mechanism. Br. J. Pharmacol. 140 (2003) 558-566
4. Andlin-Sobocki P., Jonsson B., Wittchen H.U., and Olesen J. Cost of disorders of the brain in Europe. Eur. J. Neurol. 12 (2005) 1-27
5. Ayata C., Jin H., Kudo C., Dalkara T., and Moskowitz M.A. Suppression of cortical spreading depression in migraine prophylaxis. Ann. Neurol. 59 (2006) 652-661
6. Ayata C., Shimizu-Sasamata M., Lo E.H., Noebels J.L., and Moskowitz M.A. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha 1A subunit of P/Q type calcium channels. Neuroscience 95 (2000) 639-645
7. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., and Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med. 8 (2002) 136-142
8. Brennan K.C., Beltran-Parrazal L., Lopez Valdes H.E., Theriot J., Toga A., and Charles A.C. Distinct vascular conduction with cortical spreading depression. J. Neurophysiol. 97 (2007) 4143-4151
9. Chen W.T., Fuh J.L., Lu S.R., and Wang S.J. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 41 (2001) 823-825
10. Cutrer F.M., Sorensen A.G., Weisskoff R.M., Ostergaard L., Sanchez del Rio M., Lee J., Rosen B.R., and Moskowitz M.A. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann. Neurol. 43 (1998) 25-31
11. De Fusco M., Marconi R., Silvestri L., Atorino L., Rampoldi L., Morgante L., Ballabio A., Aridon P., and Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump a2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33 (2003) 192-196
12. Dichgans M., Freilinger T., Eckstein G., Babini E., Lorenz-Depiereux B., Biskup S., Ferrari M.D., Herzog J., van den Maagdenberg A.M., Pusch M., and Strom T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A causes familial hemiplegic migraine. Lancet 366 (2005) 371-377
13. Ebersberger A., Schaible H.-G., Averbeck B., and Richter F. Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache?. Ann. Neurol. 41 (2001) 7-13
14. Fabricius M., Akgoren N., and Lauritzen M. Arginine-nitric oxide pathway and cerebrovascular regulation in cortical spreading depression. Am. J. Physiol. 269 (1995) H23-H29
15. Goadsby P.J. Cortical spreading depression- better understanding and more questions. J. Neurophysiol. 97 (2007) 3827
16. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine - current understanding and treatment. N. Engl. J. Med. 346 (2002) 257-270
17. Hadjikhani N., Sanchez del Rio M., Wu O., Schwartz D., Bakker D., Fischl B., Wong K.K., Cutrer F.M., Rosen B.R., Tootell R.B.H., Sorensen A.G., and Moskowitz M.A. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4687-4692
18. Headache Classification Committee of The International Headache Society. The international classification of headache disorders (second edition). Cephalalgia 24 (2004) 1-160
19. Kaube H., and Goadsby P.J. Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur. Neurol. 34 (1994) 30-35
20. Kaube H., Knight Y.E., Storer R.J., Hoskin K.L., May A., and Goadsby P.J. Vasodilator agents and supracollicular transection fail to inhibit cortical spreading depression in the cat. Cephalalgia 19 (1999) 592-597
21. Kow L.M., and van Harreveld A. Ion and water movements in isolated chicken retinas during spreading depression. Neurobiology 2 (1972) 61-69
22. Kraig R.P., and Nicholson C. Extracellular ionic variations during spreading depression. Neuroscience 3 (1978) 1045-1059
23. Lambert G.A., Hoskin K.L., and Zagami A.S. Cortico-NRM influences on trigeminal neuronal sensation. Cephalalgia 28 (2008) 640-652
24. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 117 (1994) 199-210
25. Lauritzen M. Cortical spreading depression in migraine. Cephalalgia 21 (2001) 757-760
26. Lauritzen M., and Hansen A.J. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J. Cereb. Blood Flow Metab. 12 (1992) 223-229
27. Lauritzen M., Rice M.E., Okada Y., and Nicholson C. Quisqualate, kainate and NMDA can initiate spreading depression in the turtle cerebellum. Brain Res. 475 (1988) 317-327
28. Leao A.A.P. Pial circulation and spreading activity in the cerebral cortex. J. Neurophysiol. 7 (1944) 391-396
29. Leao A.A.P. Spreading depression of activity in cerebral cortex. J. Neurophysiol. 7 (1944) 359-390
30. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., and Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41 (2001) 646-657
31. Marrannes R., Willems R., De Prins E., and Wauquier A. Evidence for a role of the N-methyl-d-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 457 (1988) 226-240
32. Martins-Ferreira H., Nedergaard M., and Nicholson C. Perspectives on spreading depression. Brain Res. Rev. 32 (2000) 215-234
33. Menken M., Munsat T.L., and Toole J.F. The global burden of disease study - implications for neurology. Arch. Neurol. 57 (2000) 418-420
34. Nellgard B., and Wieloch T. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol. Scand. 146 (1992) 497-503
35. Newcomb R., Abbruscato T.J., Singh T., Nadasdi L., Davis T.P., and Miljanich G. Bioavailability of Ziconotide in brain: influx from blood, stability, and diffusion. Peptides 21 (2000) 491-501
36. Olesen J. Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications. Cerebrovasc. Brain Metab. Rev. 3 (1991) 1-28
37. Olesen J., Larsen B., and Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann. Neurol. 9 (1981) 344-352
38. Ophoff R.A., Terwindt G.M., Vergouwe M.N., van Eijk R., Oefner P.J., Hoffman S.M.G., Lamerdin J.E., Mohrenweiser H.W., Bulman D.E., Ferrari M., Haan J., Lindhout D., van Ommen G.J.B., Hofker M.H., Ferrari M.D., and Frants R.R. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
39. Piper R.D., Lambert G.A., and Michalicek J. Inhalational anesthetic agents decrease susceptibility to cortical spreading depression in the cat. Proc. Soc. Neurosci. 17 (1991) 865
40. Rasmussen B.K., and Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 12 (1992) 221-228
41. Richter F., Ebersberger A., and Schaible H.G. Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression. Neurosci. Lett. 334 (2002) 123-126
42. Shimazawa M., and Hara H. An experimental model of migraine with aura: cortical hypoperfusion following spreading depression in the awake and freely moving rat. Clin. Exp. Pharmacol. Physiol. 23 (1996) 890-892
43. Shimizu K., Bari F., and Busija D.W. Glibenclamide enhances cortical spreading depression-associated hyperemia in the rat. NeuroReport 11 (2000) 2103-2106
44. Somjen G.G. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev. 81 (2001) 1065-1096
45. Steiner T.J., Findley L.J., and Yuen A.W.C. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17 (1997) 109-112
46. Storer R.J., Butler P., Hoskin K.L., and Goadsby P.J. A simple method, using 2-hydroxypropyl-b-cyclodextrin, of administering a-chloralose at room temperature. J. Neurosci. Methods 77 (1997) 49-53
47. Sugaya E., Takato M., and Noda Y. Neuronal and glial activity during spreading depression in cerebral cortex of cat. J. Neurophysiol. 38 (1975) 822-841
48. Tobiasz C., and Nicholson C. Tetrodotoxin resistant propagation and extracellular sodium changes during spreading depression in rat cerebellum. Brain Res. 241 (1982) 329-333
49. van den Maagdenberg A.M.J.M., Pietrobon D., Pizzorusso T., Kaja S., Broos L.A.M., Cesetti T., van de Ven R.C.G., Tottene A., van der Kaa J., Plomp J.J., Frants R.R., and Ferrari M. A Cacna1a knock-in migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41 (2004) 701-710
50. Wu Y.J., Boissard C.G., Greco C., Gribkoff V.K., Harden D.G., He H., L'Heureux A., Kang S.H., Kinney G.G., Knox R.J., Natale J., Newton A.E., Lehtinen-Oboma S., Sinz M.W., Sivarao D.V., Starrett Jr. J.E., Sun L.Q., Tertyshnikova S., Thompson M.W., Weaver D., Wong H.S., Zhang L., and Dworetzky S.I. (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]-3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine. J. Med. Chem. 46 (2003) 3197-3200
51. Xiong L., Zheng Y., Wu M., Hou L., Zhu Z., Zhang X., and Lu Z. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth. Analg. 96 (2003) 233-237
52. Zhang E., Hansen A.J., Wieloch T., and Lauritzen M. Influence of MK-801 on brain extracellular calcium and potassium activities in severe hypoglycemia. J. Cereb. Blood Flow Metab. 10 (1990) 136-139